ARVN
Price
$7.74
Change
-$0.00 (-0.00%)
Updated
Sep 15 closing price
Capitalization
568.25M
56 days until earnings call
PMVP
Price
$1.14
Change
-$0.09 (-7.32%)
Updated
Sep 15 closing price
Capitalization
60.41M
51 days until earnings call
Interact to see
Advertisement

ARVN vs PMVP

Header iconARVN vs PMVP Comparison
Open Charts ARVN vs PMVPBanner chart's image
Arvinas
Price$7.74
Change-$0.00 (-0.00%)
Volume$949.2K
Capitalization568.25M
PMV Pharmaceuticals
Price$1.14
Change-$0.09 (-7.32%)
Volume$962K
Capitalization60.41M
ARVN vs PMVP Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. PMVP commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and PMVP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (ARVN: $7.74 vs. PMVP: $1.14)
Brand notoriety: ARVN and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 55% vs. PMVP: 72%
Market capitalization -- ARVN: $568.25M vs. PMVP: $60.41M
ARVN [@Biotechnology] is valued at $568.25M. PMVP’s [@Biotechnology] market capitalization is $60.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARVN and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 6 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • ARVN’s TA Score: 6 bullish, 4 bearish.
  • PMVP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than PMVP.

Price Growth

ARVN (@Biotechnology) experienced а -2.52% price change this week, while PMVP (@Biotechnology) price change was -18.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.37%. For the same industry, the average monthly price growth was +6.67%, and the average quarterly price growth was +33.69%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

PMVP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($568M) has a higher market cap than PMVP($60.4M). PMVP YTD gains are higher at: -24.503 vs. ARVN (-59.624). PMVP has higher annual earnings (EBITDA): -91.02M vs. ARVN (-112.6M). ARVN has more cash in the bank: 861M vs. PMVP (142M). PMVP has less debt than ARVN: PMVP (1.02M) vs ARVN (9.9M). ARVN has higher revenues than PMVP: ARVN (373M) vs PMVP (0).
ARVNPMVPARVN / PMVP
Capitalization568M60.4M940%
EBITDA-112.6M-91.02M124%
Gain YTD-59.624-24.503243%
P/E RatioN/AN/A-
Revenue373M0-
Total Cash861M142M606%
Total Debt9.9M1.02M971%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNPMVP
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFWFF2.310.04
+1.90%
Calfrac Well Services Ltd.
DLAKF8.87N/A
N/A
Deutsche Lufthansa AG
UNIF3.95N/A
N/A
U & I Financial Corp
BAMGF14.65N/A
N/A
BROOKFIELD CORP.
GGGSF22.62N/A
N/A
Greggs Plc.

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-7.32%
CLLS - PMVP
39%
Loosely correlated
+3.46%
TERN - PMVP
36%
Loosely correlated
-1.38%
MTVA - PMVP
35%
Loosely correlated
+115.55%
CMVLF - PMVP
34%
Loosely correlated
N/A
IDYA - PMVP
33%
Loosely correlated
-0.33%
More